SynthesisFrontiers in medicine2026

Efficacy and safety of nafamostat mesylate versus heparin anticoagulation in adult kidney disease patients using continuous renal replacement therapy: a systematic review and meta-analysis.

Yao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.